세계의 약물 주입 시스템 시장 규모는 2023년에 117억 3,000만 달러, 2030년까지 194억 5,000만 달러에 달하며, 2024-2030년의 예측 기간에 CAGR로 8.85%의 성장이 전망됩니다. 약액 주입 시스템의 수요는 주로 암, 당뇨병 등 만성질환의 유병률 상승, 노년 인구의 증가, 제품 개발에서 기술의 진보 등에 의해 촉진되고 있습니다.
약물 주입 시스템 시장 역학
약물 주입 시스템 시장은 다양한 암 등 만성질환의 유병률 상승에 의해 예측 기간에 큰 성장을 기록할 전망입니다. 예를 들면 세계보건기구(WHO)(2022)가 인용한 데이터에 따르면 2020년에 세계에서 약 226만 건의 유방암, 221만 건의 폐암, 193만 건의 대장암, 141만 건의 전립선암, 109만 건의 위암이 보고되고 있습니다.
국제당뇨병연맹(IDF)(2023)가 발표한 통계에 따르면 2021년에 전 세계에서 5억 3,700만 명의 성인이 당뇨병을 앓고 있었습니다. 이 수는 2030년까지 6억 4,300만 명, 2045년까지 7억 8,300만 명로 증가할 것으로 예측됩니다.
위 사실은 전 세계에서 급증하고 있는 암과 만성질환의 한 예입니다. 만성질환은 종종 평생 동안 개인에게 영향을 미치며, 장기적인 치료 개입이 필요한 경우가 많습니다. 이를 위해 사용되는 것이 약물 주입 시스템입니다. 약물 주입 시스템은 항생제, 진통제, 호르몬제, 화학요법제 등의 약물과 영양분을 환자에게 전달하는 의료기기입니다. 이러한 시스템은 고정식 및 이동식 등 다양한 구성으로 제공됩니다. 이러한 장비는 복용량을 지속적으로 확인할 필요 없이 안전하고 정확한 약물전달을 가능하게 합니다.
또한 기술의 발전으로 프로그램 가능한 약액 주입 시스템이 개발되어 용량을 쉽게 추적할 수 있는 유량 및 알람 등의 기능을 제공합니다. 예를 들어 B. Braun Melsugen AG의 Space ecosystem은 OnlineSuiteplus가 탑재된 통합 주입 시스템입니다. 이 통합 시스템은 연결성 및 데이터 관리, 표준화된 상호운용성, 탁월한 치료, 클라우드 기반 용도 등의 기능을 제공합니다.
그러나 제품 리콜 외에도 연결 끊김, 교정 문제 등 주입 시스템과 관련된 기술적 문제는 약물 주입 시스템 시장의 성장에 대한 일정한 억제요인이 될 수 있습니다.
약물 주입 시스템 시장 부문별 분석
약물 주입 시스템 시장의 제품 부문에서 주사기 기반 주입 시스템이 큰 비중을 차지하는 것으로 추정됩니다.
이것은 제품 설계가 간단하고 적용 범위가 넓기 때문입니다.
시린지 펌프는 임상 환경에서 널리 사용되고 있습니다. 따라서 주사기를 시스템에 장착하고 요구 사항에 따라 약물전달을 프로그래밍합니다.
이러한 시스템은 소량의 약품이 필요할 때 편리합니다.
주사기 주입 시스템은 특히 영아, 신생아, 유아 등 저연령 환자에게 투여하는 데 적합합니다.
따라서 주사기 주입 시스템이 제공하는 이점으로 인해 예측 기간 중 수요가 증가할 것입니다.
북미가 전체 약물 주입 시스템 시장을 독점할 것으로 예상됩니다.
모든 지역 중 북미는 약물 주입 시스템 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 만성 요통, 당뇨병, 암과 같은 만성질환의 유행, 확립된 의료 시스템, 주요 시장 기업의 존재 등이 예측 기간 중 전체 약물 주입 시스템 시장의 성장을 가속하는 주요 영향요인이 될 것으로 예상됩니다.
질병예방통제센터(CDC)가 제공한 정보에 따르면 2019년 국민건강영양조사(National Health Survey 2019)에 따르면 2019년까지 성인의 약 20.4%가 만성통증을 앓고 있으며, 성인의 7.4%가 업무 및 생활 활동을 자주 제한하는 만성통증(고강도 만성통증으로 간주)을 앓고 있다고 합니다. 것으로 나타났습니다. 이번 조사에서 고부하 만성통증과 만성통증은 65세 이상에서 더 큰 영향을 미치며, 나이가 들수록 악화되는 것으로 나타났습니다.
세계의 약물 주입 시스템 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인과 과제, 기업과 제품 개요 등을 제공하고 있습니다.
Drug Infusion Systems Market By Product Type (Syringe Infusion Systems, Elastomeric Infusion Systems, Large Volume Infusion Systems, Enteral Infusion Systems, Patient-Controlled Analgesic Infusion Systems, Insulin Pumps, and Others), Product Placement (External and Implantable), Portability (Fixed and Ambulatory), Application (Oncotherapy, Diabetes, Analgesia, Nutrition, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of chronic diseases and increasing technological advancements
The global drug infusion systems market was valued at USD 11.73 billion in 2023, growing at a CAGR of 8.85% during the forecast period from 2024 to 2030 to reach USD 19.45 billion by 2030. The demand for drug infusion systems is primarily being boosted by the rising prevalence of chronic diseases such as cancer, diabetes, and others coupled with the increasing geriatric population and technological advancements in product development among others.
Drug Infusion Systems Market Dynamics:
The drug infusion systems market is slated to register significant growth in the forecast period due to the rising prevalence of various cancers and other chronic diseases. For instance, according to the data cited by the World Health Organization (WHO) 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020.
As per the statistics published by the International Diabetes Federation (IDF) (2023), worldwide 537 million adults were living with diabetes in 2021. This number is predicted to rise to 643 million by 2030 and 783 million by 2045.
The above-mentioned facts are examples of cancers and chronic diseases that are witnessing a rapid increase across the globe. Chronic diseases often impact individuals for the course of their lifetime and require therapeutic interventions for prolonged periods. To achieve that, drug infusion systems are used. Drug infusion systems are medical devices that are employed in the delivery of drugs such as antibiotics, pain relievers, hormones, and chemotherapy drugs as well as nutrients to the patients. These systems are available in various configurations such as stationary as well ambulatory ones. These devices offer a safe and accurate mode of drug delivery without the constant need for verifying the amount of dose being administered.
Moreover, technological advancements have led to the development of programmable drug infusion systems where flow rates and alarms among other features are being offered for easy tracking of the administered doses. For instance, the Space ecosystem by B. Braun Melsugen AG is an integrated infusion system that comes with the OnlineSuiteplus. This integrated system offers features such as connectivity and data management and standardized interoperability, outstanding therapy, and cloud-based applications among other features.
However, product recalls as well as technical problems associated with infusion systems such as disconnection, and issues in calibration may prove to be certain restraints to the drug infusion systems market growth.
Drug Infusion Systems Market Segment Analysis:
Drug Infusion Systems Market by Product Type (Syringe Infusion Systems, Elastomeric Infusion Systems, Large-Volume Infusion Systems, Enteral Infusion Systems, Patient-Controlled Analgesic Infusion Systems, Insulin Pumps, and Others), Product Placement (External and Implantable), Portability (Fixed and Ambulatory), Application (Oncotherapy, Diabetes, Analgesia, Nutrition, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product segment in the drug infusion systems market, syringe-based infusion systems are estimated to account for a significant share of the market.
This is due to their simple product design and wide applicability.
Syringe pumps are extensively used in clinical settings as the majority of the medications are available in syringe forms. Therefore, a syringe is fitted into the system and programmed for the delivery of the drug as per the requirement.
These systems are useful in the delivery of low medication volumes for medication required in small quantities.
Syringe infusion systems are particularly ideal for dose administration in younger patients such as babies, neonates, and young children.
Hence, owing to the advantages offered by syringe infusion systems, their demand will increase during the forecast period.
North America is expected to dominate the Overall Drug Infusion Systems Market:
Among all the regions, North America is expected to account for the largest share of the drug infusion systems market. The growing prevalence of chronic diseases such as chronic low back pain, diabetes, and cancers, a well-established healthcare system along with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the drug infusion systems market over the forecast period.
As per the facts provided by the Centers for Disease Prevention and Control (CDC), according to the National Health Survey 2019, about 20.4% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited work or life activities (considered as high impact chronic pain) in 2019. It was observed in the survey that high-impact chronic pain and chronic pain affected people over 65 and above more commonly and worsen with age.
As per the figures mentioned by the American Cancer Society 2021, it was estimated that 1.9 million new cancer cases have been diagnosed in the United States in 2021. Also, according to the data provided by the CDC in 2021, around 1,752,735 new cases of cancer were reported in the US in 2019. As per Globocan 2021 data, there were around 61,152 new cases of leukemia recorded in 2020 in the United States.
As these indications require long-term disease management, drug infusion systems prove to be extremely useful devices in the administration of pain management therapies as well as chemotherapy.
Moreover, the US houses a large number of key players in the market which can be attributed to the conducive product development environment along with better opportunities in terms of market access to the end users.
In June 2019, Ivenix Inc received 510k approval from the US Food and Drug Administration for their Ivenix Infusion System, which was the first and only large-volume pump and infusion system designed with the new FDA infusion guidelines, first adopted in 2014.
Therefore, with the presence of a large patient pool, along with an active regulatory body as well as active key market players in the country and the region, the market outlook for drug infusion systems is expected to be promising in the US and North America.
Drug Infusion Systems Market Key Players:
Some of the key market players operating in the drug infusion systems market include B. Braun Melsungen AG, Medtronic, BD, PROMECON GmbH, arcomed ag, Fresenius Kabi AG, Microport Scientific Corporation, Teleflex Incorporated., Smiths Medical, Baxter, Ivenix Inc, Terumo Corporation, Insulet Corporation., FLOWONIX MEDICAL INC, Intera Oncology and others.
Recent Developmental Activities in Drug Infusion Systems Market:
In September 2020, B. Braun Melsungen received 510k clearance from the US FDA for their SpaceStation MRI to allow Space® infusion pumps. These systems are meant for the delivery of medications to patients within the MRI suites.
In May 2020, Baxter received the CE mark approval and regulatory approval from Australia's Therapeutic Goods Administration (TGA) for their Evo IQ Syringe Infusion System. The system can be employed in the delivery of small volumes of fluids and other medications to patients in a controlled manner.
Key Takeaways from the Drug Infusion Systems Market Report Study
Market size analysis for current drug infusion systems market size (2023), and market forecast for 5 years (2024-2030)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global drug infusion systems market.
Various opportunities available for the other competitor in the drug infusion systems market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current drug infusion systems market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for drug infusion systems market growth in the coming future?
Target Audience who can be benefited from this Drug Infusion Systems Market Report Study
Drug infusion systems products providers
Research organizations and consulting companies
Drug infusion systems-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in drug infusion systems
Various End-Users who want to know more about the drug infusion systems market and the latest technological developments in the drug infusion systems market.
Frequently Asked Questions for Drug Infusion Systems Market:
Drug Infusion Systems are medical devices that help in the administration of drugs such as pain relievers, antibiotics, and chemotherapy drugs to patients. These systems are also used in the administration of nutrients as well.
The global drug infusion systems market was valued at USD 11.73 billion in 2023, growing at a CAGR of 8.85% during the forecast period from 2024 to 2030 to reach USD 19.45 billion by 2030.
Some of the factors positively influencing the drug infusion systems market are the increasing prevalence of chronic diseases, and various cancers, the rising geriatric population, and technological advancement in product development.
Some of the prominent market players operating in the drug infusion systems market include B. Braun Melsungen AG, Medtronic, BD, PROMECON GmbH, arcomed ag, Fresenius Kabi AG, Microport Scientific Corporation, Teleflex Incorporated., Smiths Medical, Baxter, Ivenix Inc, Terumo Corporation, Insulet Corporation., FLOWONIX MEDICAL INC, Intera Oncology and others.
North America is expected to account for the highest revenue share in the drug infusion systems market during the forecast period. Factors such as access to better healthcare, a rising number of patients suffering from chronic diseases such as diabetes, and chronic back pain, and increasing product launches in the region are expected to drive the growth of the North American Drug Infusion Systems market.